cs.LGOct 12, 2026

AutoNovo: Agentic Program Search Discovers Transferable Nucleic Acid Design Algorithms

Authors: Joel Shor, Subhashini Venugopalan

Organizations: AI Bio Design, Allen Institute & Move37 Labs · Google Research

Abstract

In-silico optimization of nucleic acids relies on predictive oracles that imperfectly capture biological function, so sequences optimized against one model may exploit model-specific artifacts and fail to generalize to independent models. Recent studies have shown that not all designers generalize equally well to independent models. In this work, we use agentic program search to iteratively propose, execute, evaluate, and revise code for nucleic-acid designers. We describe the successful strategies used to prompt the search. AutoNovo designers achieved the best observed mean among the evaluated methods on 3/3 DNA-design tasks in terms of in-silico performance, and 6/6 transfer tasks in terms of independent models. The designers come from a family of discovered nucleic acid designers rather than a single universal best designer. We plan to release the resulting designers. These results are the first steps in creating nucleic acid designers that maximize cross-model generalization, and thus improving the odds that in-silico designed sequences reflect real biology.

Figures & tables

Explore similar work

Mar 30, 2026

What an Autonomous Agent Discovers About Molecular Transformer Design: Does It Transfer?

Deep learning models for drug-like molecules and proteins overwhelmingly reuse transformer architectures designed for natural language, yet whether molecular sequences benefit from different designs has not been systematically tested. We deploy autonomous architecture search via an agent across three sequence types (SMILES, protein, and English text as control), running 3,106 experiments on a single GPU. For SMILES, architecture search is counterproductive: tuning learning rates and schedules alone outperforms the full search (p = 0.001). For natural language, architecture changes drive 81% of improvement (p = 0.009). Proteins fall between the two. Surprisingly, although the agent discovers distinct architectures per domain (p = 0.004), every innovation transfers across all three domains with <1% degradation, indicating that the differences reflect search-path dependence rather than fundamental biological requirements. We release a decision framework and open-source toolkit for molecular modeling teams to choose between autonomous architecture search and simple hyperparameter tuning.
Apr 6, 2026

General Multimodal Protein Design Enables DNA-Encoding of Chemistry

Evolution is an extraordinary engine for enzymatic diversity, yet the chemistry it has explored remains a narrow slice of what DNA can encode. Deep generative models can design new proteins that bind ligands, but none have created enzymes without pre-specifying catalytic residues. We introduce DISCO (DIffusion for Sequence-structure CO-design), a multimodal model that co-designs protein sequence and 3D structure around arbitrary biomolecules, as well as inference-time scaling methods that optimize objectives across both modalities. Conditioned solely on reactive intermediates, DISCO designs diverse heme enzymes with novel active-site geometries. These enzymes catalyze new-to-nature carbene-transfer reactions, including alkene cyclopropanation, spirocyclopropanation, B-H, and C(sp3^3)-H insertions, with high activities exceeding those of engineered enzymes. Random mutagenesis of a selected design further confirmed that enzyme activity can be improved through directed evolution. By providing a scalable route to evolvable enzymes, DISCO broadens the potential scope of genetically encodable transformations. Code is available at https://github.com/DISCO-design/DISCO.
May 25, 2026

The Montparnasse Algorithm for RNA Design

RNA design consists of discovering a nucleotide sequence that optimizes predefined criteria, such as secondary structure. It is useful for synthetic biology, medicine, and nanotechnology. We propose Montparnasse, a Monte Carlo search framework based on Generalized Nested Rollout Policy Adaptation, augmented with a problem-specific prior, slow and long adaptation at level 1, and a lexicographic multicriteria evaluation. Montparnasse solves all 100 puzzles of the Eterna100 V1 benchmark consistently faster than DesiRNA, the previous state of the art, across all time limits, reaching full coverage more than three times faster overall. On messenger RNA secondary structure optimization for hemoglobin alpha, it identifies sequences with more paired bases than the MFE-optimal solution of LinearDesign.